These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15816994)

  • 1. Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans.
    Colquhoun DM; Jackson R; Walters M; Hicks BJ; Goldsmith J; Young P; Strakosch C; Kostner KM
    Eur J Clin Invest; 2005 Apr; 35(4):251-8. PubMed ID: 15816994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients.
    Shin MJ; Chung N; Lee JH; Jang Y; Park E; Jeon KI; Chung JH; Seo BY
    Int J Cardiol; 2007 May; 118(2):173-7. PubMed ID: 17005272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia.
    Human JA; Ubbink JB; Jerling JJ; Delport R; Vermaak WJ; Vorster HH; Lagendijk J; Potgieter HC
    Clin Chim Acta; 1997 Jul; 263(1):67-77. PubMed ID: 9247729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients.
    Liu CS; Lii CK; Chang LL; Kuo CL; Cheng WL; Su SL; Tsai CW; Chen HW
    Nutr Res; 2010 Feb; 30(2):118-24. PubMed ID: 20226997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
    Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
    Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia.
    Chu CS; Kou HS; Lee CJ; Lee KT; Chen SH; Voon WC; Sheu SH; Lai WT
    Biofactors; 2006; 28(3-4):177-84. PubMed ID: 17473378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction.
    Silver MA; Langsjoen PH; Szabo S; Patil H; Zelinger A
    Am J Cardiol; 2004 Nov; 94(10):1306-10. PubMed ID: 15541254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.
    De Caterina R; Cipollone F; Filardo FP; Zimarino M; Bernini W; Lazzerini G; Bucciarelli T; Falco A; Marchesani P; Muraro R; Mezzetti A; Ciabattoni G
    Circulation; 2002 Nov; 106(20):2543-9. PubMed ID: 12427649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S; Schuster H; Barter P; Watkins C; Kallend D;
    Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients.
    Pereira EC; Bertolami MC; Faludi AA; Sevanian A; Abdalla DS
    Free Radic Biol Med; 2004 Nov; 37(9):1440-8. PubMed ID: 15454283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
    Grodzińska L; Starzyk D; Bieroń K; Goszcz A; Korbut R
    Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):413-9. PubMed ID: 15910404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination treatment with coenzyme Q10 and simvastatin in patients with coronary atherosclerosis].
    Chapidze G E ; Kapanadze SD; Dolidze NK; Latsabidze NE; Bakhutashvili ZV
    Kardiologiia; 2006; 46(8):11-3. PubMed ID: 17047594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.
    Molcányiová A; Stancáková A; Javorský M; Tkác I
    Pharmacol Res; 2006 Sep; 54(3):203-7. PubMed ID: 16737822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short term simvastatin use in patients with heart failure of ischemic origin. Changes of blood lipids, markers of inflammation and left ventricular function].
    Smetanina IN; Vaulin NA; Masenko VP; Gratsianskiĭ NA
    Kardiologiia; 2006; 46(5):44-9. PubMed ID: 16858354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q10 and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study.
    Kaikkonen J; Nyyssönen K; Tomasi A; Iannone A; Tuomainen TP; Porkkala-Sarataho E; Salonen JT
    Free Radic Res; 2000 Sep; 33(3):329-40. PubMed ID: 10993487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
    Mortensen SA; Leth A; Agner E; Rohde M
    Mol Aspects Med; 1997; 18 Suppl():S137-44. PubMed ID: 9266515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lifestyle on plasma levels of the IGF system and the antioxidants coenzyme Q10 and vitamin E in Kenyan rural and urban populations.
    Theuri G; Dallner G; Brismar K; Tekle M
    Growth Horm IGF Res; 2013 Jun; 23(3):68-75. PubMed ID: 23452916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Caso G; Kelly P; McNurlan MA; Lawson WE
    Am J Cardiol; 2007 May; 99(10):1409-12. PubMed ID: 17493470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.